StockData
ADMA Biologics, Inc. logo

ADMA Biologics, Inc. (ADMA) stock

ADMANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 17/3028% below fair value
$13.63+0.16 (+1.19%)

Close on Nov 17, 2026Market cap $3.05BP/E 19.5Yield –

ADMA Biologics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

ADMA Biologics's market cap was $2.97B on Nov 11, 2026, against $4.57B a year earlier. Over the last 5 years it ranged from $195.02M to $5.63B, with a median of $1.94B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$2.97B-31.6%
2025Dec 31, 2025$4.35B+7.2%
2024Dec 31, 2024$4.05B+296.9%
2023Dec 29, 2023$1.02B+33.8%
2022Dec 30, 2022$763.49M+291.5%
2021Dec 31, 2021$195.02M+11.6%
2020Dec 31, 2020$174.75M-26.4%
2019Dec 31, 2019$237.27M+114.2%
2018Dec 31, 2018$110.78M+100.6%
2017Dec 29, 2017$55.22M-16.3%
2016Dec 30, 2016$65.98M-23.7%
2015Dec 31, 2015$86.45M-16.7%
2014Dec 31, 2014$103.79M+126.6%
2013Dec 31, 2013$45.79M–

More ADMA Biologics figures

See a number that looks wrong?